The Cooperative Program for Modeling Clinical Transplantation (CPMCT) funds collaborative, quantitative modeling projects that aim to improve outcomes in organ transplantation through computational simulation, risk prediction, and mechanistic understanding of transplant immunology and pharmacology. It exists to bridge the gap between basic transplant science and clinical practice by supporting interdisciplinary teams that develop and validate predictive models for graft survival, immunosuppression optimization, and personalized post-transplant care.
Selection Criteria
- Scientific merit and innovation of the proposed modeling approach
- Relevance to clinical transplantation (e.g., graft rejection, immunosuppression, organ allocation)
- Qualifications and track record of the applicant(s) in computational modeling and transplant biology
- Feasibility of the research plan and data access (e.g., clinical datasets, registries)
- Potential for clinical translation and impact on patient outcomes
- Collaborative nature of the project (interdisciplinary team preferred)
- Appropriate budget justification and resource allocation
Past Winners / Cohort Profiles
Past awardees typically include mid-career or senior researchers with established track records in transplant immunology, biostatistics, or systems biology, often affiliated with academic medical centers or NIH-funded consortia. Named examples are not available on the sparse page, but archetypes include principal investigators with prior NIH R01 funding, co-investigators from clinical transplant programs, and modelers with experience in pharmacokinetics/pharmacodynamics or machine learning applied to electronic health records.
Ideal Candidate Fingerprint
The platonic ideal applicant is a PhD-level computational biologist or biostatistician with a strong publication record in transplant modeling, access to large clinical transplant datasets, and a collaborative network including transplant surgeons and immunologists. They demonstrate prior success in securing NIH funding and propose a clearly translational project with validated or high-quality data sources.
Recommended Framing
Eniola should frame their CCT model as a novel computational framework for predicting and preventing maladaptive reward-memory consolidation, which can be repurposed to model immunosuppression adherence and graft rejection risk in transplant patients. Their independent research, Bayesian modeling expertise, and collaborations with top neuroscientists (Berridge, Gershman) provide a strong foundation for proposing a quantitative model of patient behavior and pharmacological response in post-transplant care. Emphasize the Africa angle by highlighting how such a model could address adherence challenges in low-resource transplant settings, leveraging their Nigerian context and independent research track record.
Watch Out
Applicant lacks a PhD or current academic affiliation, which may be a disadvantage for a program typically targeting established researchers. No direct experience in clinical transplantation or transplant immunology. The program likely requires access to transplant patient data, which Eniola does not currently have. Age and career stage (pre-PhD) may fall outside the typical early-career window for this NIH cooperative program.